Skip to content


Tremfya (guselkumab) is an antibody pharmaceutical. Guselkumab was first approved as Tremfya on 2017-07-13. It is used to treat psoriasis in the USA. It has been approved in Europe to treat psoriasis.
Trade Name Tremfya
Common Name Guselkumab
Indication psoriasis
Drug Class Monoclonal antibodies: fully human, interleukins as target
Get full access now